Chongqing Pharscin Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 362.52 million compared to CNY 432.03 million a year ago. Revenue was CNY 367.63 million compared to CNY 435.74 million a year ago.

Net income was CNY 51.97 million compared to CNY 56.27 million a year ago. Basic earnings per share from continuing operations was CNY 0.1296 compared to CNY 0.1404 a year ago. Diluted earnings per share from continuing operations was CNY 0.1296 compared to CNY 0.1404 a year ago.